Not yet recruiting
Acute respiratory distress syndrome
Not yet recruitingStudy on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)
Registered drug
Study on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)
Registered drug
- Disease:Acute respiratory distress syndrome
- Substances:PirfenidoneSodium Chloride
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Pirfenidone
- Sponsor:Ospedale San Raffaele S.r.l.
